In this extensive meta-analysis, our objective was to provide insights into the comparative outcomes of administering sacubitril/valsartan versus ACE inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) to individuals who have suffered from acute myocardial infarction (MI). The gene discussed is ACE; the disease is acute myocardial infarction.